Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ISIS

Ionis Pharmaceuticals, (ISIS)

Ionis Pharmaceuticals,
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ISIS
DateTimeSourceHeadlineSymbolCompany
01/06/20106:00AMPR Newswire (US)Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ISIS
01/05/20107:00AMPR Newswire (US)Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001NASDAQ:ISIS
12/21/20097:15AMPR Newswire (US)Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to TevaNASDAQ:ISIS
11/23/20097:00AMPR Newswire (US)Isis Pharmaceuticals (Nasdaq: ISIS) Letter to ShareholdersNASDAQ:ISIS
10/20/20096:00AMPR Newswire (US)Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceNASDAQ:ISIS
09/09/20096:00AMPR Newswire (US)Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged ConferenceNASDAQ:ISIS
08/06/20097:23AMDow Jones NewsIsis 2Q Loss Narrows, Helped By Genzyme PartnershipNASDAQ:ISISIsis Pharmaceuticals Inc.
08/06/20096:00AMPR Newswire (US)Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009NASDAQ:ISIS
08/04/20096:00AMPR Newswire (US)Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth ConferenceNASDAQ:ISIS
05/20/200912:45PMDow Jones NewsUPDATE: Genzyme, Isis Cholesterol Drug Data Raise QuestionsNASDAQ:ISISIsis Pharmaceuticals Inc.
05/20/20099:06AMDow Jones NewsGenzyme, Isis Cholesterol Drug Meets Goal In Late StudyNASDAQ:ISISIsis Pharmaceuticals Inc.
05/07/20096:54AMDow Jones NewsIsis Swings To 1Q Profit Amid Gain, Partnership RevenueNASDAQ:ISISIsis Pharmaceuticals Inc.
02/14/20067:00AMPR Newswire (US)OncoGenex Appoints New CFO and Board MemberNASDAQ:ISIS
08/16/20058:18AMPR Newswire (US)OncoGenex Announces Completion of $12.8 Million Venture FinancingNASDAQ:ISIS
 Showing the most relevant articles for your search:NASDAQ:ISIS